Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

Background. The benefit of dose-escalated hypofractionated radiotherapy using intensity-modulated radiotherapy (IMRT) in prostate cancer is not established. We report 5-year outcome and long-term toxicity data within a phase II clinical trial. Materials and Methods. 60 men with predominantly high-ri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Thomson, David, Merrick, Sophie, Swindell, Ric, Coote, Joanna, Kelly, Kay, Stratford, Julie, Wylie, James, Cowan, Richard, Elliott, Tony, Logue, John, Choudhury, Ananya, Livsey, Jacqueline
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388303/
https://ncbi.nlm.nih.gov/pubmed/22792470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/450246
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados